「ac」の検索結果
132件:16~20件目を表示
-

CATALIN_TE_C3_20220805
理化学的知見 一般名:ピレノキシン (Pirenoxine) 〔JAN〕 化学名:1-Hydroxy-5-oxo-5 -pyrido[3, 2- ]phenoxazine- 3-carboxylic acid 構造式: 分子式:C16H8N2O5 分子量:308.25 性 状:ピレノキシンは黄褐色の粉末で、においはなく、 味は僅かに苦い。 ジメチルスルホキシドに極めて溶けにくく、水、ア セトニトリ...
https://www.senju.co.jp/system/files/product_other_file/2022-09/CATALIN_TE_C3_20221101.pdf -

July 16, 2024 General Announcement: Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Senju has successfully completed Phase III clinical trials in Japan for the novel Dry Eye Disease tr...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716_0.pdf -

-3-(1,1-Dimethylethyl)amino-2-hydroxypropyloxy]-3,4-dihydroquinolin-2(1H)-one monohydrochloride (IUPAC) ラタノプロスト (+)-Isopropyl(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclope...
https://www.senju.co.jp/system/files/2024-01/Mikeluna_IF_20240111.pdf -

July 16, 2024 General Announcement: Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Senju has successfully completed Phase III clinical trials in Japan for the novel Dry Eye Disease tr...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716.pdf -

August 20, 2026 General Announcement: Senju Pharmaceutical Co., Ltd. Senju initiated Phase III Clinical Trials in Japan for "SJP-0049" for the treatment of Allergic Conjunctivitis Senju Phar...
https://www.senju.co.jp/system/files/content_news/2026-08/ENG_20260820_0.pdf